Secondary Endpoints in Vaccine Efficacy Trials: Not Just an Afterthought
View Presentation *Karen Goldenthal, Bethesda Biologics Consult Keywords: The selection of secondary endpoints requires careful consideration and prioritization, especially with regard to their potential inclusion in a future package insert. Approaches to secondary endpoints for vaccine clinical trials, including examples, will be presented.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC